NeuroDiscovery ltd

NeuroDiscovery Ltd

NeuroDiscovery Ltd (NeuroDiscovery) is a global research and development company listed on the ASX (ASX Code: NDL).

NeuroDiscovery operates in the global Life Science sector focusing on commercialisation and development of opportunities in the field of neurology.

NeuroDiscovery has a 100% equity interest in NeuroSolutions Ltd, a UK based biotechnology company which is a leading provider of electrophysiology services to the biopharmaceutical industry and which has a pipeline of drug candidates under development with a current focus on the treatment of pain.